Advertisement

AAPS PharmSciTech

, Volume 8, Issue 4, pp 16–24 | Cite as

Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles

  • K. Vivek
  • Harivardhan Reddy
  • Ramachandra S. R. MurthyEmail author
Article

Abstract

The purpose of this research was to study the effect of the lipid matrix on the entrapment of olanzapine (OL). OL-loaded solid lipid nanoparticles (SLNs) were prepared using lipids like glyceryl monostearate (GMS), Precirol ATO 5 (PRE), glyceryl tristearate (GTS), and Witepsol E85 (WE 85)—and poloxamer 407 and hydrogenated soya phosphatidylcholine as stabilizers—using a hot melt emulsification high-pressure homogenization technique, and then characterized by particle size analysis, zeta potential, differential scanning calorimetry (DSC), and powder X-ray diffraction (pXRD). Homogenization at 10 000 psi for 3 cycles resulted in the formation of SLNs with a mean particle size of ∼190 nm for the 4 lipids investigated. The highest partition coefficient for OL between the melted lipid and pH 7.4 phosphate buffer (pH 7.4 PB) was obtained with GTS. The entrapment efficiency was in the following order: GTS SLNs>PRE SLNs>WE 85 SLNs>GMS SLNs. DSC and pXRD showed that much of the incorporated fraction of OL existed in the amorphous state after incorporation into SLNs. A sharp increase in the flocculation of the SLN dispersions was observed upon addition of 0.6 M aqueous sodium sulfate solution. Nanoparticle surface hydrophobicity was in the following order: GTS SLNs>PRE SLNs>WE 85 SLNs>GMS SLNs. A significant increase in size and zeta potential was observed for GTS SLN and WE 85 SLN dispersions stored at 40°C. Release of OL from the SLNs was sustained up to 48 hours in pH 7.4 PB and obeyed Higuchi’s release kinetics.

Keywords

Olanzapine solid lipid nanoparticles surface hydrophobicity electrolyte-induced flocculation in vitro release 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heiati H, Tawashi R, Phillips NC. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.J Microencapsul. 1998;15:173–184.PubMedCrossRefGoogle Scholar
  2. 2.
    Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles.Int J Pharm. 1996;129:159–173.CrossRefGoogle Scholar
  3. 3.
    Westesen K, Bunjes H, Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading and sustained release potential.J Control Release. 1997;48:223–236.CrossRefGoogle Scholar
  4. 4.
    Cavalli R, Gasco MR, Morel S. Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters.STP Pharma Sci. 1992;2:514–518.Google Scholar
  5. 5.
    Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications.Adv Drug Deliv Rev. 2001;47:165–196.PubMedCrossRefGoogle Scholar
  6. 6.
    Siekmann B, Westesen K. Submicron-sized parenteral carrier systems based on solid lipids.Pharm Pharmacol Lett. 1992;1:123–126.Google Scholar
  7. 7.
    Bever KA, Perry PJ. Olanzapine: a serotonin-dopamine receptor antagonist for antipsychotic therapy.Am J Health Syst Pharm. 1998;55:1003–1016.PubMedGoogle Scholar
  8. 8.
    Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.J Control Release. 2004;95:627–638.PubMedCrossRefGoogle Scholar
  9. 9.
    Reddy LH, Vivek K, Bakshi N, et al. Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): preparation, characterization, in vitro drug release and pharmacokinetic evaluation.Pharm Dev Technol. 2006;11:167–177.PubMedCrossRefGoogle Scholar
  10. 10.
    Subramanian N, Murthy RSR. Use of electrolyte induced flocculation technique for an in vitro steric stability study of steric stabilized liposome formulations.Pharmazie. 2003;59:74–76.Google Scholar
  11. 11.
    Gessner A, Waicz R, Lieske A, et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption.Int J Pharm. 2000;196:245–249.PubMedCrossRefGoogle Scholar
  12. 12.
    Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art.Eur J Pharm Biopharm. 2000;50:161–177.PubMedCrossRefGoogle Scholar
  13. 13.
    Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles.J Biotechnol. 2004;113:151–170.PubMedCrossRefGoogle Scholar
  14. 14.
    Freitas C, Muller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase.Eur J Pharm Sci. 1999;47:125–132.Google Scholar
  15. 15.
    Huang SK, Martin FJ, Jay G, et al. Extravasation and transcytosis of liposomes in Kaposi’s sarcoma—like dermal lesions of transgenic mice bearing HIV Tat gene.Am J Pathol. 1993;143:10–14.PubMedGoogle Scholar
  16. 16.
    Reddy LH, Murthy RSR. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation.AAPS PharmSciTech [serial online]. 2005;6:Article 24.Google Scholar
  17. 17.
    Carstensen H, Muller BW, Muller RH. Adsorption of ethoxylated surfactants on nanoparticles, I: characterization by hydrophobic interaction chromatography.Int J Pharm. 1991;67:29–37.CrossRefGoogle Scholar
  18. 18.
    Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs.Int J Pharm. 2002;242:121–128.PubMedCrossRefGoogle Scholar
  19. 19.
    Jenning V, Gohla S. Comparison of wax and glyceride solid lipid nanoparticles (SLN®).Int J Pharm. 2000;196:219–222.PubMedCrossRefGoogle Scholar
  20. 20.
    Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions.Int J Pharm. 1998;168:221–229.CrossRefGoogle Scholar
  21. 21.
    Sato K. Crystallization of fats and fatty acids. In: Garti N, Sato K, eds.Crystallization and Polymorphism of Fats and Fatty Acids. New York, NY: Marcel Dekker; 1988:227–266.Google Scholar
  22. 22.
    Vivek K, Harivardhan Reddy L, Murthy RSR. Comparative study of some biodegradable polymers on the entrapment efficiency, release behavior of etoposide from microspheres.Pharm Dev Technol. In press.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2007

Authors and Affiliations

  • K. Vivek
    • 1
  • Harivardhan Reddy
    • 1
  • Ramachandra S. R. Murthy
    • 1
    Email author
  1. 1.Drug Delivery Research Laboratory, Center of Relevance and Excellence in NDDS, Pharmacy Department, GH Patel Building, Donor’s Plaza, FatehgunjM.S. UniversityGujaratIndia

Personalised recommendations